Safety and Efficacy Study of CUBICIN (Daptomycin) Under Conditions of Actual Use

Complicated Skin and Skin Structure Infections and Bacteremia Including Right-sided Endocarditis Clinical Trial

Official title: A Descriptive Study of the Efficacy and Safety of CUBICIN (Daptomycin) Under Conditions of Actual Use in the Philippines

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to monitor the safety and efficacy of CUBICIN under conditions of actual use in patients who are diagnosed with complicated Skin and Skin Structure infection (cSSI) or Staphylococcus aureus bacteria including right-sided endocarditis and are prescribed CUBICIN by their physician.

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Bacteremia
• Complicated Skin and Skin Structure Infections and Bacteremia Including Right-sided Endocarditis
• Endocarditis

• NCT number: NCT01219114
• Study type: Observational
• Source: AstraZeneca
• Status: Withdrawn
• Phase: N/A
• Start date: October 2010
• Completion date: November 2013